Interestingly, blockade of IL-1 signaling by treatment with IL-1R antagonists or genetic ablation of IL-1R results in marked resistance to the development of atherosclerosis in the APOE model (Chi et al., 2004). This evidence concerns the gene IL1A and atherosclerosis.